The effectiveness of racecadotril in the treatment of rotavirus infection in children
I.I. Nezghoda, O.M. Naumenko, A.A. Asaulenko and 5 more
Aktualʹnaâ Infektologiâ · 2020
doi:10.22141/2312-413x.8.2.2020.199733 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The article deals with the effectiveness of the use of racecadotril preparation as a pathogenetic agent in the treatment of rotavirus infection in children. There were 40 patients under the age of 5 years with rotavirus infection under observation. All children underwent a set of general laboratory studies. To establish the etiological factor, immunochromatographic analysis was used to detect rotavirus antigen, and bacteriological examination of the feces — to study bacterial flora. Comprehensive treatment included basic therapy according to protocols. Children of the main group (n = 20) received the antisecretory drug racecadotril in an age-related dosage from the first day of inpatient treatment. The use of this drug has influenced the main clinical symptoms of rotavirus infection in children — accelerated the elimination of vomiting and normalization of the consistency of feces, and also allowed reducing the duration of diarrheal syndrome, which also allowed us to decrease the time of inpatient treatment in an infectious disease hospital.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.